Bray Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.86M | Sell |
19,796
-5,368
| -21% | -$832K | 0.77% | 39 |
|
|
2024
Q3 | $4.08M | Sell |
25,164
-755
| -3% | -$120K | 1% | 29 |
|
|
2024
Q2 | $3.79M | Sell |
25,919
-544
| -2% | -$80.9K | 0.95% | 29 |
|
|
2024
Q1 | $4.19M | Sell |
26,463
-92
| -0.3% | -$14.6K | 1.06% | 28 |
|
|
2023
Q4 | $4.16M | Buy |
26,555
+2
| +0% | +$307 | 1.15% | 25 |
|
|
2023
Q3 | $4.14M | Buy |
26,553
+92
| +0.3% | +$15.2K | 1.26% | 24 |
|
|
2023
Q2 | $4.38M | Sell |
26,461
-154
| -0.6% | -$24.9K | 1.31% | 21 |
|
|
2023
Q1 | $4.13M | Sell |
26,615
-19
| -0.1% | -$3.07K | 1.2% | 26 |
|
|
2022
Q4 | $4.7M | Sell |
26,634
-1,524
| -5% | -$263K | 1.46% | 18 |
|
|
2022
Q3 | $4.6M | Sell |
28,158
-65
| -0.2% | -$11K | 1.44% | 17 |
|
|
2022
Q2 | $5.01M | Sell |
28,223
-73
| -0.3% | -$13K | 1.49% | 18 |
|
|
2022
Q1 | $5.01M | Buy |
28,296
+126
| +0.4% | +$21.4K | 1.29% | 21 |
|
|
2021
Q4 | $4.82M | Buy |
28,170
+1,566
| +6% | +$256K | 1.18% | 26 |
|
|
2021
Q3 | $4.3M | Buy |
26,604
+182
| +0.7% | +$31.1K | 1.1% | 27 |
|
|
2021
Q2 | $4.35M | Buy |
26,422
+531
| +2% | +$87.9K | 1.12% | 27 |
|
|
2021
Q1 | $4.25M | Buy |
25,891
+750
| +3% | +$121K | 1.17% | 25 |
|
|
2020
Q4 | $3.96M | Buy |
25,141
+418
| +2% | +$61.7K | 1.15% | 22 |
|
|
2020
Q3 | $3.68M | Buy |
24,723
+169
| +0.7% | +$25K | 1.3% | 21 |
|
|
2020
Q2 | $3.45M | Buy |
24,554
+518
| +2% | +$75.5K | 1.33% | 20 |
|
|
2020
Q1 | $3.15M | Sell |
24,036
-216
| -0.9% | -$30.6K | 1.44% | 19 |
|
|
2019
Q4 | $3.54M | Sell |
24,252
-815
| -3% | -$111K | 1.26% | 24 |
|
|
2019
Q3 | $3.24M | Sell |
25,067
-704
| -3% | -$92.8K | 1.27% | 25 |
|
|
2019
Q2 | $3.59M | Buy |
25,771
+891
| +4% | +$123K | 1.38% | 21 |
|
|
2019
Q1 | $3.48M | Buy |
24,880
+313
| +1% | +$41.9K | 1.44% | 21 |
|
|
2018
Q4 | $3.17M | Buy |
24,567
+457
| +2% | +$63.7K | 1.59% | 17 |
|
|
2018
Q3 | $3.33M | Sell |
24,110
-56
| -0.2% | -$7.44K | 1.47% | 21 |
|
|
2018
Q2 | $2.93M | Sell |
24,166
-37
| -0.2% | -$4.62K | 1.37% | 22 |
|
|
2018
Q1 | $3.1M | Sell |
24,203
-735
| -3% | -$99.3K | 1.45% | 20 |
|
|
2017
Q4 | $3.48M | Sell |
24,938
-260
| -1% | -$36.2K | 1.67% | 16 |
|
|
2017
Q3 | $3.28M | Sell |
25,198
-119
| -0.5% | -$15.8K | 1.73% | 16 |
|
|
2017
Q2 | $3.35M | Sell |
25,317
-477
| -2% | -$60.9K | 1.84% | 16 |
|
|
2017
Q1 | $3.21M | Sell |
25,794
-1,198
| -4% | -$143K | 1.82% | 18 |
|
|
2016
Q4 | $3.11M | Sell |
26,992
-138
| -0.5% | -$15.9K | 1.86% | 18 |
|
|
2016
Q3 | $3.21M | Buy |
27,130
+739
| +3% | +$89.7K | 1.93% | 11 |
|
|
2016
Q2 | $3.2M | Buy |
+26,391
| New | +$3M | 1.99% | 9 |
|
|
2016
Q1 | – | Sell |
-24,423
| Closed | -$2.51M | – | 112 |
|
|
2015
Q4 | $2.51M | Buy |
24,423
+1,333
| +6% | +$134K | 1.59% | 19 |
|
|
2015
Q3 | $2.15M | Buy |
23,090
+1,515
| +7% | +$147K | 1.37% | 19 |
|
|
2015
Q2 | $2.1M | Sell |
21,575
-1,675
| -7% | -$168K | 1.21% | 19 |
|
|
2015
Q1 | $2.34M | Buy |
23,250
+3,065
| +15% | +$312K | 1.39% | 18 |
|
|
2014
Q4 | $2.11M | Buy |
+20,185
| New | +$2.13M | 1.37% | 18 |
|
Other funds holding JNJ
Bray Capital Advisors's JNJ Position: Q4 2024 in Review
Bray Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 21% in Q4 2024, selling an estimated $832K and leaving 19,796 shares worth $2.86M. The position accounts for 0.77% of the portfolio, ranked #39.
Bray Capital Advisors first reported a position in JNJ in Q4 2014 and has held it in 40 quarters since. The position peaked at $5.01M in Q1 2022. 4,104 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.
- Bray Capital Advisors held 19,796 shares of Johnson & Johnson worth $2.86M as of Q4 2024.
- Bray Capital Advisors sold 5,368 Johnson & Johnson shares in Q4 2024, an estimated $832K.
- Johnson & Johnson made up 0.77% of Bray Capital Advisors's portfolio in Q4 2024, its #39 holding.
- Bray Capital Advisors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 40 quarters since.
- Bray Capital Advisors's Johnson & Johnson position peaked at $5.01M in Q1 2022.
- 4,104 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.
Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.